OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond
Mirta Mosca, Maria Concetta Nigro, Rachele Pagani, et al.
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1803-1803
Open Access | Times Cited: 23

Systemic and local immunosuppression in glioblastoma and its prognostic significance
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
Mengdi Fu, Huimei Zhou, Jiaxin Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

PD-1/PD-L1 blockade therapy with atezolizumab: a new paradigm in the treatment of non-small cell lung cancer (NSCLC)
Samaneh Moradi, Pedram Sarikhani, Rafid Jihad Albadr, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression
Yunqiang Zhang, Ye Yuan, Jun Zhang, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 14, pp. 1168-1168
Open Access | Times Cited: 22

Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
Ke Ma, Yulei Qiao, Hao Wang, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 22, pp. 1478-1478
Open Access | Times Cited: 21

Prognostic nomogram on clinicopathologic features and serum indicators for advanced non-small cell lung cancer patients treated with anti-PD-1 inhibitors
Rong Chai, Yinxing Fan, Jiayi Zhao, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 17, pp. 1078-1078
Open Access | Times Cited: 13

Epigenetic alterations fuel brain metastasis via regulating inflammatory cascade
Shailendra Kumar Maurya, Asad Rehman, Mohd Ali Abbas Zaidi, et al.
Seminars in Cell and Developmental Biology (2022) Vol. 154, pp. 261-274
Open Access | Times Cited: 7

The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review
Xinyu Song, Fan Jiang, Zhu Liang, et al.
Journal of Thoracic Disease (2021) Vol. 13, Iss. 8, pp. 5093-5103
Open Access | Times Cited: 9

Combination of albumin concentration and neutrophil-to-lymphocyte ratio for predicting overall survival of patients with non-small cell lung cancer
Jinsen Weng, Jieping Huang, Wei Yu, et al.
Journal of Thoracic Disease (2021) Vol. 13, Iss. 9, pp. 5508-5516
Open Access | Times Cited: 8

Low prognostic nutrition index predicts poorer quality of life in late-stage lung cancer
Zhaohui Zhang, Aiping Chen, Fenglan Xie, et al.
Annals of Palliative Medicine (2020) Vol. 9, Iss. 6, pp. 3976-3984
Open Access | Times Cited: 5

New first-line treatment strategies for advanced lung squamous cell carcinoma
Xiuyu Cai, Hui Yu, Yanyu Cai, et al.
Translational Lung Cancer Research (2020) Vol. 9, Iss. 2, pp. 414-417
Open Access

Page 1

Scroll to top